Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in talks with several healthcare providers and leading hospitals to export the COVID-19 kits.
US FDA gave Emergency Use Authorization (EUA) to STANDARD M nCoV Real-Time Detection Kit made by SD BIOSENSOR back in April 23, 2020. With the EUA, SD BIOSENSOR has the authority to supply STANDARD M nCoV Real-Time Detection Kit across the US. STANDARD M nCoV Real-Time Detection Kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. This is RT-PCR test that amplifies and diagnoses a specific gene sequence of COVID-19.
Federal Emergency Management Agency (FEMA), an agency within the US Department of Homeland Security, has already purchased $5.2 million USD of SD Biosensor's test kits back in April 2020.
Hyo-Keun, Lee CEO of SD BIOSENSOR said that "We have been providing quality kits since 2010. Our HIV, Malaria and Syphilis test kits are already on the World Health Organization (WHO) list of prequalified in vitro diagnostic products. And we are proud to know that our COVID-19 kits will help facilitate in the fight against the spread of the coronavirus and possibly save lives. We will continue to provide quality products to help improve the health of all people around the world"
Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR will help provide much needed COVID-19 Kits to medical professionals. We hope our efforts will contribute in the fight against the coronavirus."
About Yuyu Pharma
Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.
Yuyu pharma contact Point
Global Sales Team
Franklin Park / [email protected]
Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-a
Caption - STANDARD(TM) M nCoV Real-Time Detection kit
Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-b
Caption - Yuyu Pharma Will Export COVID-19 Test Kits to the Global Market
True Corporation Public Company Limited appoints Khun Nakul Sehgal as the Chief Financial Officer ending the Co-CFO structure.
Honda Announces Losses Associated with Reassessment of Automobile Electrification Strategy; Revision to Forecast for Consolidated Financial Results; and Future Direction
Amata posts record 3.1bn-baht profit for 2025 as investment surge continues
Amata Corp. Expects Continued FDI Flows to Support Industrial Land Sales in 2026 After Record Net Profit in 2025
Thoresen Shipping Strengthens Fleet with New Ultramax "Juniper Point" on One-Year Charter
Bridgestone Wins "BEST SELLING TYRE Award by Grand Prix" for 28th Consecutive Year in CAR & BIKE OF THE YEAR 2026, Reinforcing Leadership in Thailand's Tyre Market
TPBI Wins Future Trends Awards 2026 in The Better World Corporate Awards Category "Leading of Environmental Product," Reinforcing Its Commitment to Environmentally Responsible Packaging
Huawei Cloud Strengthens Data & AI Leadership in Thailand, Empowering Financial Institutions with Cloud-Native Database Innovation
Ascott Announces Key Leadership Appointments to Drive Commercial Excellence in Thailand and Laos